Rethinking albuminuria as a marker to drive treatment in congestive heart failure
This editorial refers to ‘Albuminuria as a marker of systemic congestion in patients with heart failure’ by E.M. Boorsma, et al., https://doi.org/10.1093/eurhea
Related Articles
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials
In this prespecified pooled analysis of the STEP-HFpEF and STEP-HFpEF DM trials, semaglutide was superior to placebo in improving heart failure-related symptoms and physical limitations,…
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials
In this prespecified pooled analysis of the STEP-HFpEF and STEP-HFpEF DM trials, semaglutide was superior to placebo in improving heart failure-related symptoms and physical limitations,…
The Effect of Using a Remote Patient Management Platform in Optimizing Guideline-Directed Medical Therapy in Heart Failure Patients: A Randomized Controlled Trial
AbstractBackgroundGuideline-directed medical therapy (GDMT) remains underutilized in patients with heart failure with reduced ejection fraction, leading to morbidity and mortality.ObjectivesThe Med…
The Effect of Using a Remote Patient Management Platform in Optimizing Guideline-Directed Medical Therapy in Heart Failure Patients: A Randomized Controlled Trial
AbstractBackgroundGuideline-directed medical therapy (GDMT) remains underutilized in patients with heart failure with reduced ejection fraction, leading to morbidity and mortality.ObjectivesThe Med…
The Effect of Using a Remote Patient Management Platform in Optimizing Guideline-Directed Medical Therapy in Heart Failure Patients: A Randomized Controlled Trial
AbstractBackgroundGuideline-directed medical therapy (GDMT) remains underutilized in patients with heart failure with reduced ejection fraction, leading to morbidity and mortality.ObjectivesThe Med…
The Effect of Using a Remote Patient Management Platform in Optimizing Guideline-Directed Medical Therapy in Heart Failure Patients: A Randomized Controlled Trial
AbstractBackgroundGuideline-directed medical therapy (GDMT) remains underutilized in patients with heart failure with reduced ejection fraction, leading to morbidity and mortality.ObjectivesThe Med…
Growth differentiation factor-15 (GDF-15) and clinical outcomes in patients with chronic heart failure
Heart failure (HF) is associated with increased mortality and hospitalizations. Biomarkers have an important role in the early diagnosis of HF, as well as in…
Medicare to Cover Wegovy When Patients Also Have Heart Disease
US News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news…
Physiology and Clinical Utility of HeartMate Pump Parameters
There are an estimated 300,000 patients in the United States living with heart failure (HF) who may be eligible for advanced HF therapies, specifically left…
Transfusion Strategy in Myocardial Infarction and Anemia | NEJM
Correspondence from The New England Journal of Medicine — Transfusion Strategy in Myocardial Infarction and Anemia